• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. POD; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. POD; HCG, KRD Back to Search Results
Catalog Number RBYPOD6
Medical Device Problem Codes Physical Resistance/Sticking (4012); Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
The patient was undergoing a coil embolization procedure in the internal iliac artery (iia) using pod coils, a non-penumbra microcatheter, and an angiographic catheter.It should be noted that the patient's anatomy was tortuous and calcified.During the procedure, the physician encountered resistance while advancing a pod coil in the middle of the microcatheter and the coil became stuck.Upon retraction, resistance was also encountered and, subsequently, the pod coil unintentionally detached inside the middle of the microcatheter.Therefore, the microcatheter containing the detached pod coil was removed and the pod coil was flushed out on the back table.The procedure was completed using the same microcatheter to successfully implant seven ruby coils into the target location, and a stent-graft was also used.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Evaluation of the returned pod coil confirmed that the embolization coil was detached from its pusher assembly.Evaluation revealed that the pet lock was intact, and the pull wire was within its original position.If the pod coil is retracted against resistance, the pusher assembly may elongate beyond the reach of the pull wire, and result in the embolization coil detaching from the pusher assembly.Based on the reported complaint, the root cause of resistance could not be determined.Further evaluation revealed kinks throughout the length of the pusher assembly.This damage was incidental to the reported complaint and may have occurred during packaging of the device for return to penumbra.Penumbra products are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POD
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key15998754
Report Number3005168196-2022-00577
Device Sequence Number6737991
Product Code HCG
UDI-Device Identifier00814548019611
UDI-Public814548019611
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K173614
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/21/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberRBYPOD6
Device Lot NumberF00002107
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/08/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/23/2022
Supplement Date Received by Manufacturer12/16/2022
Initial Report FDA Received Date12/16/2022
Supplement Report FDA Received Date12/21/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/15/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-